Insider Transactions Reported by 19 Insiders of Entero Therapeutics, Inc.

Symbol
ENTO on Nasdaq
Industry
Pharmaceutical Preparations
Location
777 Yamato Road, Suite 502, Boca Raton, FL

Insiders trading volume in the past year

Entero Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
David Hoffman Director $381K Jan 3, 2023
Chaitan Khosla Director $107K Jun 11, 2024
Edward Borkowski Director $85K Jan 2, 2024
Alastair Riddell Director $85K Jan 2, 2024
Mary Theresa Coelho Director $85K Jan 2, 2024
Charles J. Casamento Director $83.7K Jan 2, 2024
James Sapirstein Chairman and CEO, Director $38.3K Jul 2, 2024
Sarah Romano Chief Financial Officer $11.1K -$465 -4.03% Jan 6, 2025
Geordan G. Pursglove Director Aug 11, 2025
Eric Corbett Director Feb 5, 2025
Manpreet Uppal Director Feb 3, 2025
Timothy Ramdeen Director Aug 9, 2024
Jason David Sawyer Director Aug 11, 2025
Richard Paolone Interim CEO, Director Feb 3, 2025
Daniel Schneiderman Chief Financial Officer Jan 3, 2022
James Pennington Chief Medical Officer Jan 3, 2022
Jack Syage President & COO, Director Mar 13, 2024
Gregory Oakes Director Jan 3, 2022
Vern Schramm Director Jan 3, 2022

Recent Insider Transactions by Companies or Individuals for Entero Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.